Bone density firm CompuMed has received approval from China's State Food and Drug Administration (SFDA) for its OsteoGram bone density screening software.
CompuMed received clearance to market OsteoGram for screening, diagnosing, and monitoring osteoporosis, according to the Los Angeles-based firm. CompuMed said it would work with Chinese OEMs to target the market.
Related Reading
CompuMed wins Arizona ECG contract, July 10, 2008
CompuMed teams with Osteometer MediTech, May 29, 2008
CompuMed wins West Virginia contract, May 1, 2008
CompuMed unveils new features for OsteoGram, November 27, 2007
CompuMed advances revenues in Q3, August 15, 2007
Copyright © 2008 AuntMinnie.com